Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Effects of GM Confused with Those of Farming Practices: Conko Letter to Financial Times
Published in The Financial Times Published in The Financial Times September 6, 2000, Wednesday London Edition 1 …
Products
Throwing Precaution to the Wind: The Perils of the Precautionary Principle
From the August/September issue of CEI UpDate Mom always said, “Better safe than sorry.” Dad, on the other hand, believed…
Op-Eds
Resistance Dropping to Biotech Foods: Kemp Op-Ed in Chicago Tribune
Published in the Chicago Tribune Published in the Chicago Tribune August 25, 2000 In spite of an ill-considered,…
Op-Eds
Canada Misses a Fat Chance: Henry Miller Op-Ed in the National Post
Published in the National Post (Canada) July 25, 2000 Canadian regulators’ decision to ban the fat substitute olestra runs against both…
News Release
CEI Comments to USDA on Proposed Organic Rules
COMMENTS OF THE COMPETITIVE ENTERPRISE INSTITUTE TO THE UNITED STATES DEPARTMENT OF AGRICULTURE, AGRICULTURAL MARKETING SERVICE,…
Op-Eds
Labelling And Risk: The Case Of Bioengineered Foods
More and more, consumers are basing their food purchases on individual preferences about food content. For many consumers this means a focus on nutrition or…